| Bacterial biofilm eradication agents: a current review AD Verderosa, M Totsika, KE Fairfull-Smith Frontiers in chemistry 7, 495483, 2019 | 490 | 2019 |
| Metals to combat antimicrobial resistance A Frei, AD Verderosa, AG Elliott, J Zuegg, MAT Blaskovich Nature Reviews Chemistry 7 (3), 202-224, 2023 | 203 | 2023 |
| Combination therapies for biofilm inhibition and eradication: a comparative review of laboratory and preclinical studies S Hawas, AD Verderosa, M Totsika Frontiers in cellular and infection microbiology 12, 850030, 2022 | 63 | 2022 |
| Ciprofloxacin-nitroxide hybrids with potential for biofilm control AD Verderosa, C de la Fuente-Núñez, SC Mansour, J Cao, TK Lu, ... European Journal of Medicinal Chemistry 138, 590-601, 2017 | 45 | 2017 |
| Synthesis and evaluation of ciprofloxacin-nitroxide conjugates as anti-biofilm agents AD Verderosa, SC Mansour, C De La Fuente-Núñez, REW Hancock, ... Molecules 21 (7), 841, 2016 | 38 | 2016 |
| Nitroxide functionalized antibiotics are promising eradication agents against Staphylococcus aureus biofilms AD Verderosa, R Dhouib, KE Fairfull-Smith, M Totsika Antimicrobial Agents and Chemotherapy 64 (1), 10.1128/aac. 01685-19, 2019 | 22 | 2019 |
| Siderophore conjugates to combat antibiotic-resistant bacteria B Rayner, AD Verderosa, V Ferro, MAT Blaskovich RSC Medicinal Chemistry 14 (5), 800-822, 2023 | 19 | 2023 |
| Moraxella catarrhalis NucM is an entry nuclease involved in extracellular DNA and RNA degradation, cell competence and biofilm scaffolding A Tan, WS Li, AD Verderosa, LV Blakeway, T D. Mubaiwa, M Totsika, ... Scientific reports 9 (1), 2579, 2019 | 19 | 2019 |
| Bacterial biofilm eradication agents: a current review. Front Chem 7: 824 AD Verderosa, M Totsika, KE Fairfull-Smith | 18 | 2019 |
| Eradicating uropathogenic Escherichia coli biofilms with a ciprofloxacin–dinitroxide conjugate AD Verderosa, J Harris, R Dhouib, M Totsika, KE Fairfull-Smith MedChemComm 10 (5), 699-711, 2019 | 18 | 2019 |
| Bacterial biofilm eradication agents: a current review. Front Chem. 2019; 7: 824 AD Verderosa, M Totsika, KE Fairfull-Smith PUBMED, 2019 | 14 | 2019 |
| Isothiazolone–Nitroxide Hybrids with Activity against Antibiotic-Resistant Staphylococcus aureus Biofilms AD Verderosa, S Hawas, J Harris, M Totsika, KE Fairfull-Smith ACS omega 7 (6), 5300-5310, 2022 | 13 | 2022 |
| Thermoresponsive polymer–antibiotic conjugates based on gradient copolymers of 2-oxazoline and 2-oxazine JR Park, AD Verderosa, M Totsika, R Hoogenboom, TR Dargaville Biomacromolecules 22 (12), 5185-5194, 2021 | 12 | 2021 |
| An in vitro Reconstructed Human Skin Equivalent Model to Study the Role of Skin Integration Around Percutaneous Devices Against Bacterial Infection ECL Bolle, AD Verderosa, R Dhouib, TJ Parker, JF Fraser, TR Dargaville, ... Frontiers in microbiology 11, 670, 2020 | 11 | 2020 |
| A high-throughput cell-based assay pipeline for the preclinical development of bacterial DsbA inhibitors as antivirulence therapeutics AD Verderosa, R Dhouib, Y Hong, TK Anderson, B Heras, M Totsika Scientific Reports 11 (1), 1569, 2021 | 9 | 2021 |
| Salmonella enterica BcfH Is a Trimeric Thioredoxin-Like Bifunctional Enzyme with Both Thiol Oxidase and Disulfide Isomerase Activities P Subedi, JJ Paxman, G Wang, L Hor, Y Hong, AD Verderosa, AE Whitten, ... Antioxidants & Redox Signaling 35 (1), 21-39, 2021 | 8 | 2021 |
| Profluorescent fluoroquinolone-nitroxides for investigating antibiotic–bacterial interactions AD Verderosa, R Dhouib, KE Fairfull-Smith, M Totsika Antibiotics 8 (1), 19, 2019 | 8 | 2019 |
| Loss of β-ketoacyl acyl carrier protein synthase III activity restores multidrug-resistant Escherichia coli sensitivity to previously ineffective antibiotics Y Hong, J Qin, AD Verderosa, S Hawas, B Zhang, MAT Blaskovich, ... Msphere 7 (3), e00117-22, 2022 | 7 | 2022 |
| Repeat-unit elongations to produce bacterial complex long polysaccharide chains, an O-antigen perspective Y Hong, D Hu, AD Verderosa, J Qin, M Totsika, PR Reeves EcoSal Plus 11 (1), eesp-0020-2022, 2023 | 6 | 2023 |
| Use of antiviral agents and other therapies for COVID-19 MAT Blaskovich, AD Verderosa Seminars in Respiratory and Critical Care Medicine 44 (01), 118-129, 2023 | 5 | 2023 |
